Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Thiamine-responsive maple syrup urine disease (thiamine-responsive MSUD) is a less severe variant of MSUD that manifests with a phenotype similar to intermediate MSUD but that responds positively to treatment with thiamine.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for thiamine-responsive maple syrup urine disease.
4 publications have been identified in PubMed for thiamine-responsive maple syrup urine disease. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
Upadia J (2025). [PMID: 40823510](https://pubmed.ncbi.nlm.nih.gov/40823510/). *Molecular genetics and metabolism reports*. [Case Report / Case Series]
Rostampour N (2025). [PMID: 39773751](https://pubmed.ncbi.nlm.nih.gov/39773751/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Frankel R (2025). [PMID: 40395091](https://pubmed.ncbi.nlm.nih.gov/40395091/). *J Investig Med High Impact Case Rep*. [Case Report / Case Series]
Fascetti AJ (2024). [PMID: 39113982](https://pubmed.ncbi.nlm.nih.gov/39113982/). *Heliyon*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center